filmov
tv
About the FCRN
Показать описание
TABLE
Рекомендации по теме
0:02:00
FcRn and the Long Half-Life of IgG Antibodies
0:01:16
About the FCRN
0:01:18
What is FcRn and What Does It Do?
0:01:50
FcRn model platform
0:01:03
What is an FcRn Blocker and How Does It Work?
0:01:20
The Role of FcRn In More Than 100 Autoimmune Diseases
0:00:45
Impact of fcRn inhibitors on IgG-mediated autoimmune disorders
0:29:19
Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors
0:04:15
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
0:18:33
FcRn Binding & Therapeutics Antibody Screening
0:21:12
JAX Tech Talk #63: Let's talk FcRN: The Translational Platform for Antibody PK Assessment
0:04:00
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
0:57:03
FcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives
0:23:05
New and emerging therapies in gMG: FcRn receptor antagonists and complement inhibition
0:00:39
neonatal Fc receptor (English) - Medical terminology for medical students -
0:00:31
Imaavy, J&J’s New FcRn Blocker for gMG, Approved by FDA
0:04:46
Zelluläre Rezeptoren: Der „neonatale“ Fc-Rezeptor FcRn
0:01:32
cosMOG: anti-FcRn agent rozanolixizumab for relapse prevention in MOGAD
0:05:15
Managing Side Effects in FcRn Therapy: Best Practices for gMG
0:20:04
FcRn Therapies 2021 Conference Humanized Cytokine Models
0:43:44
Journal Club | Anti-FcRn Treatment in Antibody-Associated Experimental Autoimmune Encephalomyelitis
0:05:15
FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy
0:02:02
ENERGY: Phase II/III study of nipocalimab in patients with wAIHA
1:04:32
FcRn Modulation as a Targeted Approach to Myasthenia Gravis Management
welcome to shbcf.ru
0:02:00
0:01:16
0:01:18
0:01:50
0:01:03
0:01:20
0:00:45
0:29:19
0:04:15
0:18:33
0:21:12
0:04:00
0:57:03
0:23:05
0:00:39
0:00:31
0:04:46
0:01:32
0:05:15
0:20:04
0:43:44
0:05:15
0:02:02
1:04:32